Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis

por Schenfeld, Jennifer, Iles, Jan, Trivedi, Mona, Accortt, Neil A.
Publicado 2017

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis

por Accortt, Neil A., Lesperance, Tamara, Liu, Mei, Rebello, Sabrina, Trivedi, Mona, Li, Youfu, Curtis, Jeffrey R.
Publicado 2018

Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity

por Sauer, Brian C., Teng, Chia-Chen, Accortt, Neil A., Burningham, Zachary, Collier, David, Trivedi, Mona, Cannon, Grant W.
Publicado 2017

Defining and characterizing sustained remission in patients with rheumatoid arthritis

por Curtis, Jeffrey R., Trivedi, Mona, Haraoui, Boulos, Emery, Paul, Park, Grace S., Collier, David H., Aras, Girish A., Chung, James
Publicado 2017

Decreased Injection Site Pain Associated with Phosphate-Free Etanercept Formulation in Rheumatoid Arthritis or Psoriatic Arthritis Patients: A Randomized Controlled Trial

por Cohen, Stanley, Samad, Ahmed, Karis, Elaine, Stolshek, Bradley S., Trivedi, Mona, Zhang, Hao, Aras, Girish A., Kricorian, Greg, Chung, James B.
Publicado 2019

Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial

por Chandran, Vinod, Malkov, Vladislav A, Ito, Kaori L, Liu, Yihua, Vestergaard, Lene, Yoon, Oh Kyu, Liu, Jinfeng, Trivedi, Mona, Hertz, Angie, Gladman, Dafna
Publicado 2023

Effect of filgotinib on health-related quality of life in active psoriatic arthritis: a randomized phase 2 trial (EQUATOR)

por Orbai, Ana-Maria, Ogdie, Alexis, Gossec, Laure, Tillett, William, Leung, Ying Ying, Gao, Jingjing, Trivedi, Mona, Tasset, Chantal, Meuleners, Luc, Besuyen, Robin, Hendrikx, Thijs, Coates, Laura C
Publicado 2020